LOS ANGELES--(EON: Enhanced Online News)--Goldberg Law PC announces that it is investigating Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) concerning possible violations of federal securities laws.
“excess tension in the pin mechanism introduced during the manufacturing process.”
If you purchased or otherwise acquired Boston Scientific shares and would like more information regarding the investigation, we encourage you to click here, or contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at email@example.com.
On February 23, 2017, Boston Scientific revealed it would be recalling its range of Lotus Valve heart devices, due to reports of an early release of a pin connecting the heart valve device to the delivery system.
Boston Scientific attributes the problem to "excess tension in the pin mechanism introduced during the manufacturing process."
When this information was revealed to investors, the value of Boston Scientific fell, causing investors harm.
If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at firstname.lastname@example.org.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.